Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2022 16:32 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Report Second Quarter 2022 Financial Results on August 15, 2022

LEXINGTON, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
July 28, 2022 16:15 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
July 28, 2022 16:05 ET | Source: AVEO Pharmaceuticals, Inc.

AVEO Oncology to Announce Second Quarter 2022 Financial Results on August 4, 2022

BOSTON, July 28, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that it will report second quarter 2022...
July 28, 2022 16:05 ET | Source: Icosavax, Inc.

Icosavax Announces Results from IVX-411 Drug Product Investigation and Outlines Additional Corporate Milestones

- Antigen component of IVX-411 found to be unstable; issue specific to molecule, with no evidence of read-through to other Icosavax programs - - Now focused on a bivalent strategy for COVID-19...
July 28, 2022 16:05 ET | Source: Larimar Therapeutics

Larimar Therapeutics Announces Presentation at the Upcoming Gordon Research Conference on Neurobiology of Brain Disorders

BALA CYNWYD, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare...
July 28, 2022 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022

SALT LAKE CITY, July 28, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its second-quarter earnings conference call on...
July 28, 2022 16:01 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences to Report Second Quarter 2022 Financial Results on August 4th, 2022

REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2022 financial results will be released after...
July 28, 2022 16:00 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Presents New Preclinical Data at the 2022 iPSC Manufacturing Summit on Synthetic Receptor Enabled Differentiation, a Novel Approach for the Differentiation and Expansion of Induced Pluripotent Stem Cells to Generate Cytotoxic Innate Lymphocytes

New data demonstrates Umoja’s synthetic receptor enabled differentiation (ShRED™) as a novel platform to differentiate and expand progenitor cells and cytotoxic innate lymphocytes using the RACRTM...
July 28, 2022 14:11 ET | Source: Modifi Biosciences

Science Publication First to Describe Modifi Bio’s Novel Approach to Fight Cancer Cells with DNA Modification

NEW HAVEN, Conn., July 28, 2022 (GLOBE NEWSWIRE) -- Modifi Biosciences announced today that the journal Science has published a critical study validating the company’s novel oncology platform based...
July 28, 2022 08:33 ET | Source: Acer Therapeutics Inc.

Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease

NEWTON, Mass. and GENEVA, Switzerland, July 28, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (Acer) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB:...